Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |